Cyntegrity & Microsoft Leadership Roundtable: Implementing Quality by Design (QbD) with AI in Clinical Trials
Don’t miss an exclusive in-person event, the Leadership Roundtable, at Messeturm Frankfurt. On 3 July, join Microsoft and Cyntegrity for a high-impact roundtable on how AI-powered Quality-by-Design (QbD) and Risk-Based Quality Management (RBQM) deliver inspection-ready trials without blowing the budget.
The event features keynotes from Microsoft’s Andrew Warrington and Cyntegrity’s CEO Artem Andrianov, PhD, followed by a panel discussion with industry experts moderated by Cyntegrity’s Dr. Johann Proeve. Attendees will also explore real-world data on cycle-time reduction, cost savings, and audit readiness.
If you’re leading Clinical Operations, Quality, Digital R&D, or Data Science, you’ll walk away with a metric framework for “trustworthy AI” aligned with ICH E6(R3), a practical playbook for safeguarding patient data while scaling automation, and benchmarks that reveal how industry peers are already cutting weeks off database lock.
Attendance is complimentary but limited to 40 delegates. Secure your spot now to connect with clinical trial leaders and explore innovative AI-driven risk management and QbD strategies.
📄Click to Download Flyer
🔗Click to Register now